All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-11780452

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Detail
1	11780452	A491C	S	S	Hepatitis B Virus Infection	View
2	11780452	A636T	S	S	Hepatitis B Virus Infection	View
3	11780452	A679C	S	S	Hepatitis B Virus Infection	View
4	11780452	C533A	S	S	Hepatitis B Virus Infection	View
5	11780452	L175F	S	S	Hepatitis B Virus Infection	View
6	11780452	N131T	S	S	Hepatitis B Virus Infection	View
7	11780452	P127T	S	S	Hepatitis B Virus Infection	View
8	11780452	S113T	S	S	Hepatitis B Virus Infection	View
9	11780452	S143T	S	S	Hepatitis B Virus Infection	View
10	11780452	T113P	S	S	Hepatitis B Virus Infection	View
11	11780452	T491A	S	S	Hepatitis B Virus Infection	View
12	11780452	T531C	S	S	Hepatitis B Virus Infection	View
13	11780452	T546A	S	S	Hepatitis B Virus Infection	View
14	11780452	T581A	S	S	Hepatitis B Virus Infection	View
15	11780452	Y161F	S	S	Hepatitis B Virus Infection	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.